Lilly’s Synthetic Molecule Design and Development (SMDD) team develops synthetic active pharmaceutical ingredients and drug products from preclinical development through commercialization. The Director Late Phase Process Development will lead late-phase synthetic molecule process development, including finalizing commercial routes and processes, characterizing processes, and establishing control strategies that support Phase 3 clinical supply, registration stability, regulatory submissions, process validation, and commercial handoff. The role leads cross-disciplinary teams that may include process chemists, analytical chemists, material scientists, and engineers. It also provides oversight for external R&D, technology transfer, and campaign execution. The position is based at Lilly Technology Center-North in Indianapolis, Indiana, with potential exposure to chemicals, allergens, and loud noises and travel of 0 to 20%. The anticipated annual wage is $153,000–$264,000. Full-time equivalent employees are eligible for a company bonus, depending in part on company and individual performance. Lilly also describes a comprehensive benefits program for eligible employees, including 401(k), pension, vacation, medical, dental, vision and prescription drug coverage, flexible benefits, life insurance and death benefits, certain time-off and leave benefits, and well-being benefits.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
Ph.D. or professional degree